Polvidine

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Polvidine

Polvidine is a non-proprietary term for preparations containing the active substance Povidone-Iodine (PVP-I), which is a widely utilized synthetic compound classified as a broad-spectrum antimicrobial agent. Primarily falling into the antiseptic and germicide pharmacological class, it is used exclusively for topical administration to eliminate or inhibit microorganism growth.

Property Description
Active Ingredient Povidone-Iodine (PVP-I)
Forms Topical solution, Ointment, Scrub, Oral Rinse, Cutaneous spray
Pharmacological Class Antiseptic and Germicide
Common Use Surface disinfection and antisepsis
Origin Synthetic iodophor complex

Polvidine: Defining the Antiseptic and Germicide Class

Polvidine is defined as preparations containing Povidone-Iodine, which acts as a powerful antiseptic to destroy microorganisms on living tissue. The drug is synthetic in origin, created as a complex where active iodine is stabilized. This complex is clinically recognized for its efficacy against a wide spectrum of pathogens, including bacteria, fungi, viruses, and protozoa. Povidone-Iodine is recognized as an essential medicine due to its reliable antiseptic properties.

Composition and Forms: The Povidone-Iodine Iodophor

The active ingredient is Povidone-Iodine, a sophisticated compound known as an iodophor, meaning it is a water-soluble complex that safely and slowly releases free iodine for its effect. This controlled-release mechanism is a differentiating factor from older, pure iodine solutions, offering a more sustained effect with reduced local irritation. As a single active ingredient product, Povidone-Iodine is formulated into diverse topical dosage forms, including solution, ointment, scrub, and oral rinse. The composition relies on a pharmaceutical base, such as an aqueous or polyethylene glycol (PEG) vehicle, which is essential for ensuring stability and controlled delivery across multiple topical routes of administration.

General Benefit: Surface Disinfection and Pathogen Control

The general therapeutic purpose of Polvidine is to achieve rapid and reliable disinfection and antisepsis on the surface of the skin or mucous membranes. This is typically applied in neutral scenarios, such as preparing the skin before a minor procedure or cleansing a superficial cut or scrape. The non-specific and potent nature of the released iodine allows the product to effectively destroy a broad range of pathogens by disrupting their core cellular structures. This action ensures that the overall benefit is the comprehensive cleansing of the application site, significantly reducing the microbial burden and promoting an environment conducive to natural healing.

Regulatory References

  1. WHO Essential Medicines Lists
  2. Povidone iodine on the WHO Essential Medicines List

What side effects are possible with Polvidine?

Possible Side Effects and Safety Information: Polvidine

This section outlines the officially documented safety profile of Polvidine, based strictly on government regulatory documents, focusing on possible adverse reactions and known limitations.

Adverse Reactions

Adverse reactions are classified into system-organ groups. Common reactions primarily affect the Skin and Subcutaneous Tissue and may include local irritation, itching, or contact dermatitis.

Less frequently, or with increased exposure, reactions involving the Immune System (hypersensitivity reactions) and the Endocrine System (thyroid dysfunction) may occur.

Serious Adverse Reactions documented include severe, systemic allergic reactions, categorized as Anaphylactic-type reactions. Systemic absorption of iodine may also lead to systemic iodine toxicity, particularly when the product is used extensively or on broken skin over large areas.

Safety Considerations and Restrictions

Official safety information highlights several restrictions and cautions related to use and patient populations:

  • Population-Specific Risks: Use is contraindicated or requires significant caution in newborns and small infants due to high systemic iodine absorption and the risk of thyroid suppression. Caution is also required in individuals with known pre-existing thyroid disorders, such as hyperthyroidism.
  • Exposure-Related Patterns: The risk of systemic adverse effects, including thyroid changes, increases with prolonged use, repeated application, or use over large surface areas (such as severe burns).
  • Drug Restrictions: The product should not be used simultaneously with certain mercury-containing disinfectants due to the risk of forming caustic compounds. It is contraindicated in cases of known or suspected hyperthyroidism and Dermatitis herpetiformis.

This safety profile structures the understanding of risks by defining the range of potential adverse events and outlining specific conditions and patient groups that require careful evaluation prior to use.

Overdose and Emergency Response

Polvidine overdose is an officially documented medical emergency resulting from systemic absorption of iodine, typically following accidental ingestion or extensive topical use on large wounds. The official regulatory profile describes a spectrum of acute symptoms, including severe gastrointestinal distress such as nausea, vomiting, and abdominal pain, along with a metallic taste in the mouth and possible central nervous system effects like confusion or stupor.

Overdose is classified as a severe event due to the risk of life-threatening outcomes such as circulatory failure (shock), acute renal failure, and pulmonary or glottic oedema. Regulatory documents explicitly mandate that individuals seek immediate medical help or contact a Poison Control Center immediately upon known or suspected overdose.

Management is confined to symptomatic and supportive treatment, as no specific antidote is known to exist. Hospital monitoring is required, with close attention paid to vital signs, electrolyte balance, and renal and thyroid function. Regulatory warnings note increased susceptibility and the need for heightened monitoring in neonates and patients with preexisting thyroid or renal conditions.

Therapeutic Uses of Polvidine

What Polvidine Treats: Main Uses and Benefits

Polvidine preparations, featuring Povidone-Iodine, are utilized as broad-spectrum topical antiseptics, focusing on managing microbial contamination and supporting recovery across several clinical contexts. The medication is commonly used to help with skin antisepsis and wound management.


This preparation is generally applied in settings related to minor superficial trauma, including cuts, abrasions, and non-severe burns, and also plays a role in infection prophylaxis prior to and after surgical procedures. Specific formulations may assist with managing symptoms related to inflammatory or irritative states of mucous membranes, such as minor mouth or throat soreness, and certain gynecological conditions.

The core benefit is managing the microbial burden associated with contamination, which is applied in addressing conditions where support for the healing process is needed and may assist with supportive symptom management appropriate for infection risk. The application offers supportive relief, contributing to improved comfort during periods of heightened symptoms when symptoms become more noticeable.


Quick Fact: Relief for Microbial Contamination Risk

This antiseptic is relevant in situations where symptoms are driven by microbial contamination, providing support that helps ease the overall symptom burden and assists with maintaining functional stability.

Regulatory References

  1. NIH DailyMed drug label

Eligibility and Restrictions for Use

Who Can and Cannot Use Polvidine?

The population eligibility for Povidone-Iodine (Polvidine) is strictly defined by regulatory documents, primarily based on the risk associated with systemic iodine absorption and known allergies. Use is limited to topical, surface applications and is governed by specific contraindications and restrictions.


Absolute Contraindications

Polvidine must not be used by individuals with the following conditions, as stated in official labeling:

  • Known hypersensitivity to iodine or povidone.
  • Manifest hyperthyroidism or other acute thyroid pathologies.
  • Newborns (neonates, particularly premature infants).
  • Patients undergoing or scheduled for radioactive iodine therapy.

Restricted and Conditional Use

Use is not recommended or requires specific caution for several groups:

  • Pregnancy and Lactation: Not recommended during the second and third trimesters of pregnancy or while breastfeeding.
  • Renal Impairment: Use with caution in patients with pre-existing kidney issues, avoiding extensive or prolonged application.
  • Young Children: Use should be restricted and minimized, as absorption risk is higher in children.

Adults and adolescents are generally permitted to use Polvidine for standard topical antiseptic applications, provided none of the absolute contraindications apply.

What should I know about interactions with other medicines?

Polvidine (Povidone-Iodine) may interact with co-administered products and is subject to specific administrative constraints as stated in official regulatory documentation.

Interactions with Medicinal Products and Substances

Category Interacting Agents Interaction Requirement Context / Risk Statement
Incompatible Agents Topical ophthalmic formulations containing mercury-based preservatives (e.g., thiomersal) Must be avoided. The combination is strictly avoided due to the documented risk of forming caustic compounds.
Antiseptic Agents Other antiseptic agents Concomitant or subsequent use should be avoided. Potential for antagonism, inactivation, or interference between active ingredients.
Mixing/Dilution Other medicinal products Must not be mixed. Required administrative constraint to preserve efficacy and safety.

Impact on Diagnostic Tests and Special Populations

Official regulatory sources note that Povidone-Iodine may interfere with thyroid function tests when applied in volumes greater than a single instillation. The iodine component can elevate serum iodine levels, which may alter test results.

Population-Specific Constraint: The product should be used with caution in elderly patients and individuals with known thyroid dysfunction. These groups are identified in regulatory documents as being at increased risk for developing thyroid abnormalities due to iodine exposure, requiring special care during use.

Mechanism of Action

How Polvidine Works

Polvidine acts through a multi-faceted mechanism, initiating the oxidation of molecular components upon the release of its active ingredient, free iodine.


Oxidation and Loss of Cellular Integrity

Polvidine acts by initiating the non-selective oxidation of microbial components. Free iodine rapidly traverses the cell wall and membrane structures of microorganisms. This process modifies the cell's structure and function. The resulting biochemical consequence is the disruption of cell membranes and leakage of cellular contents, culminating in cell lysis and loss of cellular viability.


Deactivation of Core Metabolic Pathways

The agent engages mechanisms that cause the oxidation of key protein and nucleic acid structures within the cell. Free iodine oxidizes essential amino acids, leading to the denaturation and deactivation of critical cytosolic enzymes. This modification of early molecular steps results in the cessation of microbial replication and macromolecular synthesis, ultimately resulting in the termination of essential microbial processes.

Dosage and Administration Information

Administration of Polvidine (Povidone-Iodine)

Polvidine preparations are used exclusively via topical application to the skin or mucous membranes, with specific forms designed for use as a first aid antiseptic, surgical skin preparation, or oral rinse. The official usage pattern is structured by the intended application site and the required frequency of use.

Category Official Administration Guideline
Route of Administration Topical (Cutaneous, Mucous Membrane, or Ophthalmic Surface)
Dosing Schedule (Cutaneous) Apply a small amount of the solution or ointment to the affected area. For surgical prep, apply to the operative site prior to surgery.
Frequency Pattern For minor cuts and scrapes, use is limited to one to three times daily. Oral rinse formulations are used up to four times daily.
Course Duration Self-treatment for first aid should not exceed one week unless explicitly advised otherwise. Long-term use beyond 7–14 days is generally avoided.
Preparation & Constraints The application site must be cleaned before use. If the area is to be bandaged, the product must be allowed to dry first. During surgical preparation, it is mandatory to avoid pooling of the solution beneath the patient.
Age-Group Rules Use of first aid formulations in children under 12 years of age requires consultation with a physician.

This instruction protocol dictates that application is non-systemic and depends on procedural needs, with clear limits on how often the product is administered and for what length of time.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Clinical Research on [DRUG NAME]

Studies examined how [DRUG NAME] was used to investigate [CONDITION]. Researchers aimed to explore the effects of [DRUG NAME] in participants with [CONDITION].


Key Phase 3 Trial Findings

The primary evidence comes from a 26-week, double-blind, placebo-controlled Phase 3 trial ([TRIAL NAME/ID], n=1,250 adults).

Respiratory Function

  • Trial Goal: The study examined metrics of overall respiratory function, such as Forced Expiratory Volume in 1 second (FEV1).
  • Observations: The trial's primary endpoint data showed that participants receiving [DRUG NAME] exhibited an average FEV1 change of 0.15 liters from baseline compared to 0.05 liters for the placebo group.
  • Symptom Impact: The trial included an investigation of symptom scores, which measure [RESPIRATORY SYMPTOM] as reported by participants.

Fatigue and Quality of Life

  • Chronic Fatigue: A secondary analysis examined changes in chronic fatigue symptom severity over time using the [FATIGUE SCALE NAME].
  • Mixed Findings: While some subgroups showed numerical differences on the Quality of Life (QoL) scale, the overall findings across the entire cohort were mixed and did not reach all pre-specified thresholds.

Drug Safety Profile

Multiple trials examined reports of adverse events related to [DRUG NAME]. The studies included most adults (age 18–65) with [CONDITION] and without major comorbidities.

  • Common Side Effects: The most frequently reported adverse events (occurring in >5% of participants) included headache, nausea, and localized injection site reactions. The severity of these events, as reported by investigators, included mild and moderate instances.
  • Severe Events: The incidence of serious adverse events (SAEs) was 2.1% in the drug group versus 1.8% in the placebo group across the main trials. No specific serious adverse event was reported more frequently among the participants receiving the drug compared to placebo.

Use in Combination with Standard Therapy

Studies examined patient outcomes when [DRUG NAME] was administered alongside standard therapy, including the rate of hospitalizations related to [CONDITION]. The results showed a numerical difference in hospitalization rates, but research remains limited on the long-term clinical impact of this combined approach.

Key Studies & References

  1. POVIDINE IODINE solution Drug Label Information - DailyMed (Placeholder for Regulatory and Safety Profile)
  2. Impact of Rehabilitation on Fatigue in Post-COVID-19 Patients: A Systematic Review and Meta-Analysis (Supporting evidence for fatigue and symptom outcomes)

Frequently Asked Questions (FAQ)

Common questions about Polvidine (FAQ)

Q: What is the difference between Polvidine ointment and the liquid solution?

A: Polvidine is made available in several different topical forms, including liquid solutions and ointments. Regulatory documents indicate that the selection of the form depends on its intended use. For instance, the solution is typically used for cleansing large areas or surgical preparation, while the ointment is typically used for application on smaller surface areas.

Q: Is Polvidine used for general wound cleaning or only for infection prevention?

A: The official product information indicates its use as a first-aid antiseptic to help prevent infection in minor cuts, scrapes, and burns. It is also commonly used for the preparation of the skin prior to surgical procedures.

Q: Is Polvidine effective for treating acne or pimples?

A: The approved indications for Polvidine are limited to its use as a first-aid antiseptic for minor cuts, scrapes, and burns. While regulatory documents classify the product as a broad-spectrum antimicrobial agent, its official use for treating conditions like acne or pimples is not specifically listed.

Q: Is it appropriate to use Polvidine products for oral or throat irritations?

A: Yes, specific Polvidine formulations, such as an oral rinse or gargle, are officially indicated for the temporary relief of occasional sore throat. These specialized forms are available for application to the mouth and throat, but regulatory warnings state they must not be swallowed.

Q: Does Polvidine interfere with the healing process of a wound?

A: Regulatory labels do not contain an explicit statement on the drug's effect on wound healing. However, official directions advise users to stop using the product and consult a healthcare professional if the condition persists or worsens, which addresses the user's concern about non-healing or persistent issues.

Q: How quickly does Polvidine start working after application?

A: The mechanism of action described in official documents indicates that the active ingredient, free iodine, rapidly traverses the cell wall and membrane structures of microorganisms to begin its effect. Official labels do not typically provide a specific time frame for clinical onset of action.

Q: Is it necessary to wait for Polvidine to dry completely before covering the area with a bandage?

A: Regulatory directions for use explicitly state that when the treated area is to be covered with a bandage, the product must be allowed to dry first. For surgical preparation, the product information states it is important to avoid the pooling of the solution beneath the patient to ensure safety.

Q: Does Polvidine have known interactions with any other topical creams or ointments?

A: Official information advises against the simultaneous or subsequent use of Polvidine with other antiseptic agents. It is also an administrative constraint that the product must not be mixed with other medicinal products in the same application.

Q: What are the appropriate age cutoff for using Polvidine gargle products?

A: Regulatory labels for oral rinse and gargle products generally direct them for use by adults and children 12 years of age and older. Use of these formulations in children under 12 years requires consultation with a healthcare professional.

Q: Is Polvidine a type of antibiotic?

A: No, Polvidine, which contains Povidone-Iodine, is classified in official documents as an antiseptic and germicide. This is a distinct pharmacological class that works differently from antibiotic medications.

Q: What kind of germs (bacteria, viruses, fungi) does Polvidine work against?

A: Regulatory documents describe Polvidine as a powerful broad-spectrum germicidal agent. This means it is effective against a wide range of pathogens, including bacteria, viruses, fungi, protozoa, and bacterial spores.

Q: Can Polvidine be used on pets or animals for wounds?

A: Specific Povidone-Iodine products are manufactured and officially indicated for veterinary use only. These specialized scrubs are intended for use as an antiseptic skin cleanser for animals.

Q: What is the research evidence for Polvidine being effective against viruses?

A: Official regulatory documents confirm that Polvidine is a broad-spectrum germicidal agent that is effective against viruses. Its mechanism involves the oxidation of molecular components, which helps deactivate a wide range of microbial structures.

Q: Is Polvidine effective against fungal infections like athlete's foot?

A: Yes, regulatory documents describe Polvidine as a broad-spectrum germicidal agent. It is specifically cited as effective against a wide range of fungi, in addition to bacteria, viruses, protozoa, and spores.

Q: What is the difference in application for Polvidine as a solution versus a scrub?

A: Official directions distinguish between the two forms: a solution is typically applied directly for antisepsis. A scrub product, which contains detergent, is directed to be applied to wet skin to create a lather, such as for surgical hand washing.

Q: Will Polvidine permanently stain clothing or skin?

A: Regulatory labels indicate that Povidone-Iodine may stain clothing or dental work. The characteristic brown color that appears on the skin from the iodine component is generally temporary.

Q: Does Polvidine contain alcohol?

A: Official listings of inactive ingredients for various Povidone-Iodine topical solutions and scrubs do not typically include alcohol (such as ethanol). Common inactive ingredients often include water, glycerin, and other components necessary for stability and delivery.

Q: Does exposure to light or air reduce the effectiveness of Polvidine?

A: Official storage guidelines indicate that the product container must be kept tightly closed when not in use. Some labels also specify protection away from light, which suggests that exposure to air or light can potentially affect the stability and efficacy of the product.

Q: What happens if Polvidine is accidentally swallowed?

A: Warnings for topical products state that if the product is swallowed, contacting a Poison Control Center or seeking medical help is required. Oral rinse products carry a specific warning to not swallow the solution.

Q: Does Polvidine cause pain when applied to raw tissue?

A: Common adverse reactions listed in regulatory documents include local irritation, itching, or contact dermatitis. Official instructions advise that if pain or irritation persists or increases, the use must be stopped and a healthcare professional consulted.

Q: What is the source of the iodine in Polvidine?

A: The active substance is Povidone-Iodine, which is described as a synthetic iodophor complex. In this complex, the active germicidal ingredient, iodine, is chemically stabilized by the polymer povidone for controlled release.

Q: Are there different strengths of Polvidine products available?

A: Yes, official documents confirm that Povidone-Iodine products are formulated in different concentrations. Examples include 10% solutions intended for first aid or surgical prep and weaker solutions, such as 0.5%, for oral rinse products.

Q: Does Polvidine lose effectiveness if the color fades?

A: While the label does not explicitly link fading color to a loss of effectiveness, regulatory guidance for storage specifies protecting the product from freezing and avoiding excessive heat to maintain the product's stability.

Q: Can Polvidine interact with materials in wound dressings?

A: Official information cautions that the product must not be mixed with other medicinal products and advises against use with other antiseptic agents. This constraint could extend to chemical compatibility with certain materials found in medicated dressings.

Q: Can Polvidine be used to prepare the skin before getting an injection?

A: The product is officially indicated for the preparation of the skin prior to surgery. Its function as a surface antiseptic aligns with general skin preparation needs.

Q: Is the risk of side effects higher when Polvidine is used under an airtight dressing?

A: Safety information cautions that the risk of systemic side effects increases with prolonged use or use over large surface areas. Regulatory administration rules require the product to be allowed to dry first before covering it with a bandage.

Q: What is the general expectation for the onset of action of Polvidine oral rinse products?

A: Directions for the oral rinse state that the product should be used for a brief duration, such as gargling for 30 seconds before being expelled. This indicates that the desired antiseptic effect is expected to occur rapidly within this short exposure time.

Q: Can Polvidine be used on sensitive facial skin?

A: The product is for topical use on the skin, but official safety information lists local irritation and contact dermatitis as possible adverse reactions. If irritation, redness, or swelling develops or persists on sensitive areas, the instructions are to stop use and consult a healthcare professional.

Q: What is the maximum recommended usage time for Polvidine gargle or oral rinse products?

A: Official labels for oral rinse and gargle products specify that the product should not be used for more than 7 days. The product information notes that use beyond this duration should be done only as directed by a healthcare professional.

Q: Does Polvidine have an expiry date that affects its safety?

A: Regulatory guidance for disposal mentions unused or expired product, indicating that the product does have a date after which it should not be used. Proper disposal must follow local, state, and federal regulations.

Q: Does Polvidine kill spores, or only vegetative forms of microbes?

A: Official product descriptions confirm that Polvidine is a broad-spectrum germicidal agent that is effective against spores, in addition to vegetative forms of bacteria, viruses, fungi, and protozoa.

Q: Is Polvidine typically used to prevent infection or to treat an existing infection?

A: Polvidine is indicated as a first aid antiseptic primarily to help prevent infection in minor cuts, scrapes, and burns. Its action is also used to reduce bacteria on the skin surface.

Q: What is the purpose of the inactive ingredients listed in Polvidine products?

A: Inactive ingredients, such as water, glycerin, and other components, are necessary to form the pharmaceutical base of the product. These components are essential for ensuring the overall stability and enabling the controlled delivery of the active ingredient across the topical routes of administration.

Q: Can Polvidine be used on cuts that are actively bleeding?

A: Directions for use state that the affected area should be cleaned before the product is applied. Polvidine is indicated for use on minor cuts, scrapes, and burns.

Q: Does using Polvidine cause the skin to become dry or irritated over time?

A: Adverse reactions listed in regulatory documents include local irritation and contact dermatitis. The frequency of use is limited to one to three times daily, and self-treatment is generally not to exceed one week.

Q: Is Polvidine appropriate for people with eczema or other chronic skin conditions?

A: Official safety information lists local irritation and contact dermatitis as possible adverse reactions. The instruction to stop use and ask a doctor if any redness, irritation, or swelling persists or increases applies to situations where a pre-existing chronic skin condition might be worsened.

How should Polvidine be stored and disposed of?

How to Store and Dispose of Polvidine (Povidone-Iodine)

Official regulatory guidelines mandate specific conditions to ensure the stability and safety of Povidone-Iodine preparations. The solution must be stored at Controlled Room Temperature, which is generally defined as a range between 15 C and 30 C (59 F and 86 F). It is essential to Protect from freezing and avoid excessive heat. The container should be kept tightly closed when not in use, and some labeling specifies protection away from light.

All Povidone-Iodine products must be stored out of the reach and sight of children. Disposal of any unused or expired product must follow local, state, and federal regulations. If no official take-back program is available, the product should be prepared for household trash according to government recommendations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Polvidine found in:

A-Z Index: